Liquid biopsy market classified into hospital/physician laboratories, reference laboratories, academic and research centers and other end users. Other end-users segment includes public health laboratories, pathology laboratories, and small molecular laboratories. Detailed insights on the upcoming technologies, research & development activities, and new product launches in the liquid biopsy market.
Complete report on Liquid Biopsy Market spread across 160 Pages, Profiling 11 Companies and Supported with 75 Tables and 74 Figures is now available at www.rnrmarketresearch.com/liquid-b…arket-report.html
The liquid biopsy market is expected to reach USD 1.66 Billion by 2021 from USD 0.58 Billion in 2016, growing at a CAGR of 23.4% during forecast period of 2016 to 2021. Technological advancements, increasing number of new cancer cases, availability of funding, growing awareness about liquid biopsy through conferences and government initiatives, and benefits of liquid biopsy over solid tumor biopsy are some of major factors driving growth of market.
- Pharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- Contract Research Organizations
- Research and Consulting Companies
- Liquid Biopsy Product Manufacturers and Distributors
- Hospitals and Diagnostics Centers
- Reference Laboratories
- Government and Public Laboratories
Based on cancer type, liquid biopsy market segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and other cancers (melanoma, bladder cancer, and ovarian cancer). Based on circulating biomarkers, the liquid biopsy market is segmented into circulating tumor DNA (ct DNA), circulating tumor cells (CTCs), extracellular vesicles (EVs), and other biomarkers (circulating RNA and protein).
Interested in this New Research Study the Sample Copy of this research is Available Now at www.rnrmarketresearch.com/contacts…mple?rname=640498
The liquid biopsy market is segmented based on cancer type, circulating biomarkers, products & services, end users, and regions. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and other cancers (melanoma, bladder cancer, and ovarian cancer).
1 Liquid Biopsy: Market Overview
2 Geographic Analysis: Liquid Biopsy Market, By Circulating Biomarker
3 Market Size, By End User,
4 Market Size, By Product,
5 Market Size, By Circulating Biomarker,
6 Geographical Snapshot of the Market
Key players operating in liquid biopsy market are Biocept Inc. (U.S.), Myriad Genetics (U.S.), QIAGEN (Netherlands), Roche (Switzerland), Bio-Rad Laboratories Inc. (U.S.), Trovagene Inc. (U.S.), Guardant Health, Inc. (U.S.), Janssen Diagnostics, LLC (U.S.), Fraunhofer-Gesellschaft (Germany), and MDxHealth SA (U.S.).
Click now for more Details, Queries and Corporate Order on this study “Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), Product (Instruments, Software), End User (Reference Laboratory, Research Centers) - Forecast to 2021” report @ www.rnrmarketresearch.com/contacts…ying?rname=640498 .
Lung cancer segment is expected to account for the largest share of liquid biopsy market primarily due to technological advancements and the growing demand for advanced diagnostic technologies among the large base of lung cancer patients.
A number of factors, such as technological advancements, increasing number of new cancer cases, benefits of liquid biopsy over solid tumor biopsy, availability of funding, and growing awareness about liquid biopsy through conferences and government initiatives are driving the growth of the liquid biopsy market.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.